Related Experiment Videos
Nurse-led adherence support in hypertension: a randomized controlled trial
Knut Schroeder1, Tom Fahey, Sandra Hollinghurst
1Primary Health Care, Department of Community Based Medicine, University of Bristol, UK. k.schroeder@bristol.ac.uk
Family Practice
|January 19, 2005
Summary
Nurse-led support did not improve medication adherence or blood pressure control in patients with hypertension. This intervention was also more costly than usual care, offering no clear benefit for managing high blood pressure.
Area of Science:
- Cardiovascular Medicine
- Nursing Research
- Health Services Research
Background:
- Poor medication adherence is a significant factor in uncontrolled hypertension, increasing risks of heart attack and stroke.
- Effective strategies are needed to improve adherence and blood pressure management in community settings.
Purpose of the Study:
- To assess the impact of nurse-led adherence support on medication adherence and blood pressure control.
- To compare nurse-led support against usual care for patients with uncontrolled hypertension.
Main Methods:
- A randomized controlled trial involving 245 adults with uncontrolled hypertension (>= 150/90 mmHg) from 21 UK general practices.
- Participants were assigned to either nurse-led adherence support or usual care.
- Primary outcomes included medication adherence ('timing compliance') and blood pressure levels.
Main Results:
- Baseline medication adherence was high in both groups (90.8% intervention vs. 94.5% control).
- No significant difference in medication adherence was observed at follow-up between the nurse-led support and usual care groups.
- No significant differences in systolic or diastolic blood pressure were found between the groups.
- The nurse-led intervention incurred higher projected primary care costs per consultation.
Conclusions:
- Medication adherence rates in this study exceeded previous reports.
- Nurse-led adherence support did not demonstrate a significant effect on medication adherence or blood pressure control compared to usual care.
- The intervention presented a higher cost from a primary care perspective without clear clinical benefits.